Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary results

INTRODUCTION: This study determines prognostic factors in patients with advanced urothelial cancer (UC) treated with gemcitabine-cisplatin or carboplatin (GC). MATERIAL AND METHODS: The clinical records of 30 patients with advanced UC treated with GC were retrospectively reviewed. Twenty-six patient...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Morizane, Shuichi, Iwamoto, Hideto, Yao, Akihisa, Isoyama, Tadahiro, Sejima, Takehiro, Takenaka, Atsushi
Формат: Artigo
Язык:Inglês
Опубликовано: Polish Urological Association 2012
Предметы:
Urological Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921783/
https://ncbi.nlm.nih.gov/pubmed/24578930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5173/ceju.2012.02.art1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы